[Image: masthead]

24-HOUR MH HOTLINE

800-644-9737

Outside NA: 001-209-417-3722
FOR EMERGENCIES ONLY

24-HOUR MH HOTLINE: 800-644-9737
Outside NA: 001-209-417-3722
FOR EMERGENCIES ONLY

MHAUS Recommendations

MHAUS does not intend for these recommendations to be standards, guidelines, practice parameters, or clinical requirements nor does application of these recommendations guarantee any specific outcome. Furthermore, these recommendations may be adopted, modified, or rejected according to clinical needs and restraints. MHAUS recognizes that these recommendations are subject to revision as warranted by the evolution of medical knowledge, technology, and practice. Additionally, individual MH consultant opinion may vary and variability of opinion of different responses based on given clinical situation.

 

Click to download/print/view

Table of Contents followed by completed

 

 

MHAUS Recommendations 

On topics that we are frequently asked for guidance, the following evidence-based recommendations have been developed for use in the healthcare community:

 

Click to read about The MHAUS Recommendation Development Process

 

 

 

Masseter Muscle Rigidity: Definition, Relationship to Malignant Hyperthermia, and Management
Masseter Muscle Rigidity: Definition, Relationship to Malignant Hyperthermia, and Management

Posted in 2018

Recommendations and supporting evidence. 

 

What evidence-based interventions are recommended to alleviate hyperthermia associated with Malignant Hyperthermia?
What evidence-based interventions are recommended to alleviate hyperthermia associated with Malignant Hyperthermia?

Posted in 2018

Recommendations and supporting evidence. 

 

Can Patients with a Suspected Personal or Family History of MH be Safely Anesthetized Prior to Diagnostic Testing for MH Susceptibility?
Can Patients with a Suspected Personal or Family History of MH be Safely Anesthetized Prior to Diagnostic Testing for MH Susceptibility

Posted in 2018

Recommendations and supporting evidence. 

 

How Much Dantrolene Should be Available in Facilities Where Volatile Agents are not Available or Administered, and Succinylcholine is Only Stocked on Site for Emergency Purposes?
How Much Dantrolene Should be Available in Facilities Where Volatile Agents are not Available or Administered, and Succinylcholine is Only Stocked on Site for Emergency Purposes?

Posted in 2018

Recommendations and supporting evidence. 

 

Relationship Between MH Susceptibility and Heat or Exercise Related Rhabdomyolysis
Relationship Between MH Susceptibility and Heat or Exercise Related Rhabdomyolysis

Posted in 2017

Recommendations and supporting evidence. 

 

Dantrolene Administration After an MH Event
Dantrolene Administration After an MH Event

Posted in 2017

Recommendations and supporting evidence.   

Does Noonan Syndrome Increase Malignant Hyperthermia Susceptibility?
Does Noonan Syndrome Increase Malignant Hyperthermia Susceptibility?

Posted in 2012

Recommendations and supporting evidence.

  

Adverse Effects of Heat and Exercise in Relation to MH Susceptibility
Adverse Effects of Heat and Exercise in Relation to MH Susceptibility

Posted in 2012

Recommendations and supporting evidence.  

Does Mitochondrial Myopathy (MM) Increase an Individual's Susceptibility to Malignant Hyperthermia (MH)?
Does Mitochondrial Myopathy (MM) Increase an Individual's Susceptibility to Malignant Hyperthermia (MH)?

Posted in 2012

Recommendations and supporting evidence. 

 

MH-Susceptibility and Operating Room Personnel: Defining the Risks
MH-Susceptibility and Operating Room Personnel: Defining the Risks

Posted in 2012

The contraindications for the administration of succinylcholine and the potent volatile inhalational anesthetics to Malignant Hyperthermia Susceptible (MHS) individuals are well documented and defined. However, there are no published data on risks to these individuals associated with environmental exposure to waste gases in the operating room.

 

Parturient with MHS Partner
Parturient with MHS Partner

Posted in 2012

Suggested Guidelines for management of the Pregnant-patient not believed to be at risk for MH, but WHOSE PARTNER is susceptible to malignant hyperthermia.     

Preparation of Anesthesia Workstations to Anesthetize MH Susceptible Patients
Preparation of Anesthesia Workstations to Anesthetize MH Susceptible Patients

Posted in 2012

Recommendations for the preparation of anesthesia workstations to anesthetize MH susceptible patients.       

      

Temperature Monitoring during Surgical Procedures
Temperature Monitoring during Surgical Procedures

Posted in 2012

MHAUS recommends core temperature monitoring for all patients given general anesthesia lasting more than 30 minutes. Appropriate sites for continuous electronic core temperature monitoring include the esophagus, nasopharynx, tympanic membrane (with probe in contact with the membrane), bladder, and the pulmonary artery.   

 

The MHAUS Recommendation Development Process
The MHAUS Recommendation Development Process

The MHAUS Recommendation Development Process

see also

The mission of MHAUS is to promote optimum care and
scientific understanding of MH and related disorders.